ReviewExploration of targeted anti-tumor therapy2021

Potential benefit of β-glucans as adjuvant therapy in immuno-oncology: a review.

Valeria Cognigni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.